VB Spine announced that it completed its acquisition of rights to the Xvision Spine System from Augmedics.
In February, the company announced an agreement to acquire exclusive rights to the Xvision augmented reality (AR) navigation,...
VB Spine announced that it completed its acquisition of rights to the Xvision Spine System from Augmedics.
In February, the company announced an agreement to...
ProSomnus announced that it received FDA 510(k) clearance for its RPMO₂ obstructive sleep apnea (OSA) therapy device.
San Francisco–based ProSomnus says its clearance marks the...
Adagio Medical announced that it received FDA investigational device exemption (IDE) to expand its FULCRUM-VT trial.
FULCRUM-VT evaluates the company’s vCLAS cryoablation technology for treating...
FeelTect has kicked off a clinical trial in Ireland to evaluate its wearable, pressure-sensing device for vein ulcers.
Researchers at the University of Galway will...
FeelTect has kicked off a clinical trial in Ireland to evaluate its wearable, pressure-sensing device for vein ulcers.
Researchers at the University of Galway will...
Boston Scientific announced new findings from the CHAMPION-AF trial supporting its Watchman FLX system.
Watchman FLX, Boston Scientific’s left atrial appendage closure (LAAC) device, reduces...
iPerf announced the first-in-human use of its new dual-flow femoral arterial cannula device. Lyon, France-based iPerf designed its device to integrate an additional flow...
Providence Medical Technology has enrolled the first subjects in its prospective, randomised controlled trial (RCT) assessing the CORUS-LX system to treat degenerative lumbosacral disease.
The...
VB Spine announced that it completed its acquisition of rights to the Xvision Spine System from Augmedics.
In February, the company announced an agreement to...
ProSomnus announced that it received FDA 510(k) clearance for its RPMO₂ obstructive sleep apnea (OSA) therapy device.
San Francisco–based ProSomnus says its clearance marks the...
Adagio Medical announced that it received FDA investigational device exemption (IDE) to expand its FULCRUM-VT trial.
FULCRUM-VT evaluates the company’s vCLAS cryoablation technology for treating...
FeelTect has kicked off a clinical trial in Ireland to evaluate its wearable, pressure-sensing device for vein ulcers.
Researchers at the University of Galway will...